← Leaderboards
Lisa Allyn Boardman
Mayo Clinic Coll Of Medicine, Rochester
$12,819,757
Attributed
$14,151,457
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,151,457 · 8
By mechanism
R01$10,098,712 · 4
P30$3,426,615 · 3
K07$626,130 · 1
Top collaborators
- Fotini Gounari3 shared
- Khashayarsha Khazaie3 shared
- Christopher Staley3 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Vicente E Torres$21,998,835
Others in their field
Top investigators on “Biobank”
- Leonard Freedman · Leidos Biomedical Research, Inc.$247,215,881
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Peter J O'Dwyer · University Of Pennsylvania$120,526,242
- David Heimbrook · Leidos Biomedical Research, Inc.$115,298,400
- Praduman Jain · Vignet, Inc.$102,576,382
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,456,386
Research focus
BiobankTissuesBaseClinicGenesGeneticMalignant NeoplasmsColorectal CancerGenotypeResourcesInstitutional Review BoardsFreezingProtocols DocumentationUnited StatesFecesResponseDiagnosisInflammationDesignHuman TissueTumorColonAnatomyCollection
Grant awards (35)
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen$606,007
R01 · FY2025 · CA
Clinical Core$301,910
P30 · FY2025 · DK · contact PI
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen$575,706
R01 · FY2024 · CA
Clinical Core$301,910
P30 · FY2024 · DK · contact PI
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen$593,887
R01 · FY2023 · CA
Clinical Core$250,997
P30 · FY2023 · DK · contact PI
Clinical Core$250,997
P30 · FY2022 · DK · contact PI
Clinical Core$250,997
P30 · FY2021 · DK · contact PI
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype$657,971
R01 · FY2020 · CA · contact PI
Clinical Core$245,098
P30 · FY2020 · DK · contact PI
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype$638,232
R01 · FY2019 · CA · contact PI
Clinical Core$250,997
P30 · FY2019 · DK · contact PI
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype$657,970
R01 · FY2018 · CA · contact PI
Clinical Core$308,621
P30 · FY2018 · DK · contact PI
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype$636,149
R01 · FY2017 · CA · contact PI
Clinical Core$316,272
P30 · FY2017 · DK · contact PI
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype$636,149
R01 · FY2016 · CA · contact PI
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)$428,429
R01 · FY2016 · CA · contact PI
Clinical Core$316,272
P30 · FY2016 · DK · contact PI
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)$445,549
R01 · FY2015 · CA · contact PI
Clinical Core$316,272
P30 · FY2015 · DK · contact PI
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)$368,382
R01 · FY2014 · CA · contact PI
Clinical Core$316,272
P30 · FY2014 · DK · contact PI
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)$606,147
R01 · FY2013 · CA · contact PI
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)$654,094
R01 · FY2012 · CA · contact PI
Telomere length, telomere maintenance genes and cancer risk$425,120
R01 · FY2012 · CA · contact PI
Telomere length, telomere maintenance genes and cancer risk$528,540
R01 · FY2011 · CA · contact PI
Telomere length, telomere maintenance genes and cancer risk$574,078
R01 · FY2010 · CA · contact PI
Telomere length, telomere maintenance genes and cancer risk$569,061
R01 · FY2009 · CA · contact PI
Telomere length, telomere maintenance genes and cancer risk$497,241
R01 · FY2008 · CA · contact PI
Molecular Basis of Young Onset Colorectal Cancer$125,226
K07 · FY2006 · CA · contact PI
Molecular Basis of Young Onset Colorectal Cancer$125,226
K07 · FY2005 · CA
Molecular Basis of Young Onset Colorectal Cancer$125,226
K07 · FY2004 · CA
Molecular Basis of Young Onset Colorectal Cancer$125,226
K07 · FY2003 · CA
Molecular Basis of Young Onset Colorectal Cancer$125,226
K07 · FY2002 · CA